• bladder cancer;
  • robotics;
  • cystectomy;
  • quality of life


  • To determine short-term health-related quality of life (HRQL) outcomes after robot-assisted radical cystectomy (RARC) using the Bladder Cancer Index (BCI) and European Organisation for Research and Treatment of Cancer (EORTC) Body Image Scale (BIS).

Patients and Methods

  • All patients undergoing RARC were enrolled in a quality assurance database.
  • The patients completed two validated questionnaires, BCI and BIS, preoperatively and at standardised postoperative intervals.
  • The primary outcome measure was difference in interval and baseline BCI and BIS scores.
  • Complications were identified and classified by Clavien grade.


  • In all, 43 patients completed pre- and postoperative questionnaires
  • There was a decline in the urinary domain at 0–1 month after RARC (P = 0.006), but this returned to baseline by 1–2 months.
  • There was a decline in the bowel domain at 0–1 month (P < 0.001) and 1–2 months (P = 0.024) after RARC, but this returned to baseline by 2–4 months.
  • The decline in BCI scores was greatest for the sexual function domain, but this returned to baseline by 16–24 months after RARC.
  • Body image perception using BIS showed no significant change after RARC except at the 4–10 months period (P = 0.018).


  • Based on BCI and BIS scores HRQL outcomes after RARC show recovery of urinary and bowel domains ≤6 months. Longer follow-up with a larger cohort of patients will help refine HRQL outcomes.